FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4066811000001103: Ondansetron 16mg suppositories 1 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21891701000001112 Ondansetron 16mg suppositories 1 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21891801000001115 Ondansetron 16mg suppositories 1 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 16mg suppositories 1 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Is pack of Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository false Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Has active ingredient Ondansetron false Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Has VMP Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 16mg suppositories 1 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zofran 16mg suppositories (GlaxoSmithKline) 1 suppository Is a True Ondansetron 16mg suppositories 1 suppository Inferred relationship Existential restriction modifier
Zofran 16mg suppositories (CST Pharma Ltd) 1 suppository Is a True Ondansetron 16mg suppositories 1 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start